Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc. scores highest on Torque (81) and lowest on Price (21). Its PosiPenta is 49.46 out of 100, around the middle of similar companies.
On the Penta Grid this week, Hemab Therapeutics Holdings, Inc. is Grid #293 of 837 in the Healthcare sector in United States, and Grid #1,943 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Hemab Therapeutics Holdings, Inc. | 49.46 | 21 | 33 | 51 | 81 | 60 |
| Sonida Senior Living, Inc. | 49.16 | 29 | 40 | 77 | 37 | 62 |
| Phibro Animal Health Corporation | 61.76 | 51 | 75 | 64 | 52 | 68 |
| Generate Biomedicines, Inc. | 40.10 | 19 | 27 | 44 | 47 | 63 |
| Absci Corporation | 47.10 | 12 | 43 | 74 | 58 | 48 |
| Novavax, Inc. | 56.50 | 0 | 56 | 85 | 97 | 44 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -6.94 |
| P/B ratio | 3.09 |
EEarnings
| Trailing EPS | ₹-410.12 |
| Forward EPS | ₹-241.25 |
NNitro
| Price | 2848.08 |
| 52-week high | 5249.10 |
| 52-week low | 2178.44 |
| Fall from 52-week high | 45.7% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹13,303 Cr |
| Insider holding | 10.78% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Hemab Therapeutics Holdings, Inc.'s PosiPenta score?
Hemab Therapeutics Holdings, Inc.'s PosiPenta is 49.46 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Hemab Therapeutics Holdings, Inc. stand on the Penta Grid?
On the Penta Grid this week, Hemab Therapeutics Holdings, Inc. is Grid #293 of 837 in the Healthcare sector in United States, and Grid #1,943 of 4,000 in United States.
Which PosiPenta pillar is strongest for Hemab Therapeutics Holdings, Inc.?
Torque (durability), with a score of 81 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Hemab Therapeutics Holdings, Inc.?
Price (valuation), with a score of 21 out of 100: weaker than most similar companies.
Has Hemab Therapeutics Holdings, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.75 points, from 47.71 to 49.46.
PositoAI is for research and education only and is not investment advice.